DA
Dr. Ravikumar Akunuri
The Wistar Institute, Incozen Therapeutics Pvt Ltd, National Institute of Pharmaceutical Education and Research, University College of Pharmaceutical Sciences (UCPSc))
0000-0003-4898-5753
Employment
-
The Wistar Institute Postdoctoral Fellow2022 - Present
-
Incozen Therapeutics Pvt Ltd Senior Project Associate2022 - 2022
Education
-
National Institute of Pharmaceutical Education and Research Ph.D2016 - 2021
-
National Institute of Pharmaceutical Education and Research MS (Pharm.)2011 - 2013
-
University College of Pharmaceutical Sciences (UCPSc)) Bachelor of Pharmacy2006 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (34)
- NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors Save
- (E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model Save
- Cryo‐ <scp>EM</scp> structure of the dopamine transporter with a novel atypical non‐competitive inhibitor bound to the orthosteric site Save
- Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction Save
- Synthesis and Biological Evaluation of Diphenyl Ether‐Linked Quinolone Derivatives as Antibacterial Agents Save
- Small molecule inhibitors of NLRP3 inflammasome and GSK-3β in the management of traumatic brain injury: A review Save
- Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo Save
- Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors Save
- Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents Save
- Synthesis and biological evaluation of 1-phenyl-4,6-dihydrobenzo[b]pyrazolo[3,4-d]azepin-5(1H)-one/thiones as anticancer agents Save